Altoida Receives Investment from Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator to Advance Precision Neurology
PDF) A Virtual Reality Scenario for All Seasons: The Virtual Classroom | Ioannis Tarnanas, Albert Rizzo, J Galen Buckwalter, and Galen Buckwalter - Academia.edu
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
EIT Health wins 3 of 5 top European innovation awards for solutions in Alzheimer's and stroke-risk detection, and cancer treat
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Greek Researcher Receives Top European Innovation Award (video)
Our Leadership Team | Altoida
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas (@ITarnanas) / Twitter
Altoida AG - top100startup.ch
Ioannis Tarnanas - EIT Innovators Award 2018 winner - YouTube
New Research Field Could Save Billions For Pharmaceutical Companies And Patients
Stream Atlantic Fellows | Listen to Equity in Brain Health playlist online for free on SoundCloud
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
The power to innovate: winners of EIT Awards 2018 announced | EIT
The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review
Όρος Kilauea κόβω πρόωρος ioannis tarnanas altoida Ισπανία Ανάκληση Θεαματικός
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
DEPARTMENT OF INFORMATICS | Forbes article about the Ionian Universitys Laboratory of Bioinformatics and Human Electrophysiology research
Simone Accornero - EIT CHANGE Award 2018 winner - YouTube
DxA Speakers-NEW | Alzheimer's Drug Discovery Foundation
Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study | Global Brain Health Institute
